Series A - Latus Bio
Investment Firm
Overview
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.
Announced Date
May 02, 2024
Funding Type
Series A
Highlights
Location
N/A
Social
Participant Investors
6
Round Details and Background
Latus Bio raised $54000000 on 2024-05-02 in Series A
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients.
Company Funding History
1
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| May 02, 2024 |  Series A - Latus Bio | 7 | - | 54.0M |
Recent Activity
News
May 09, 2024
Pulse 2.0 - Latus Bio: Patient-Centric And Product-Oriented Gene Therapy Company Raises $54 Million
News
May 06, 2024
pitchbook.com - Global VC deals for May 6, 2024
News
May 03, 2024
KED Global - Samsung Life Science invests in US biotech firm Latus Bio
News
May 03, 2024
The Korea Herald - Samsung Life Science Fund invests in US gene therapy firm
News
May 03, 2024
KBR - Samsung Life Science Fund invests in US gene therapy firm Latus Bio
News
May 02, 2024
Business Wire - Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing